CVKD
Cadrenal Therapeutics, Inc.Company with tickers: CVKD
CIK
1937993
CUSIP
127636207
Shares Outstanding
3,078,247
13F Activity (30d)
18 filings
16 filers
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 3, 4 and 5. Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Shares |
|---|---|---|---|---|
| 2026-05-28 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 2,989 |
| 2026-05-22 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 1,165 |
| 2026-05-22 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Other | 20,000 |
| 2026-05-12 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 3,298 |
| 2026-05-11 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 6,476 |
| 2026-05-11 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Other | 200,000 |
| 2025-12-29 | Szot Matthew K |
Director | Sell | 9,933 |
| 2025-12-02 | Golden Lee Scott |
EVP & CHIEF MEDICAL OFFICER | Award | 5,000 |
| 2025-11-24 | Golden Lee Scott |
EVP & CHIEF MEDICAL OFFICER | Other | 1,667 |
| 2025-10-27 | Szot Matthew K |
Director | Sell | 1,800 |
| 2025-10-27 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 1,315 |
| 2025-10-24 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 1,129 |
| 2025-10-24 | Szot Matthew K |
Director | Sell | 1,800 |
| 2025-10-24 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Other | 200,000 |
| 2025-10-13 | Szot Matthew K |
Director | Sell | 1,800 |
| 2025-10-13 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 1,800 |
| 2025-10-09 | Szot Matthew K |
Director | Sell | 1,693 |
| 2025-10-09 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 1,800 |
| 2025-10-09 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Other | 200,000 |
| 2025-10-06 | Szot Matthew K |
Director | Sell | 107 |
| 2025-10-02 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 500 |
| 2025-10-02 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Other | 200,000 |
| 2025-10-01 | Szot Matthew K |
Director | Sell | 1,700 |
| 2025-10-01 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 881 |
| 2025-09-29 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Other | 200,000 |
| 2025-09-29 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 419 |
| 2025-09-29 | Szot Matthew K |
Director | Sell | 100 |
| 2025-09-25 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 6,790 |
| 2025-09-25 | Szot Matthew K |
Director | Sell | 10,900 |
| 2025-09-24 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 2,581 |
| 2025-09-24 | Szot Matthew K |
Director | Sell | 1,500 |
| 2025-09-24 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Other | 200,000 |
| 2025-08-28 | Szot Matthew K |
Director | Sell | 400 |
| 2025-08-28 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 1,193 |
| 2025-08-27 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Sell | 3,836 |
| 2025-08-27 | Szot Matthew K |
Director | Sell | 1,600 |
| 2025-08-27 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Other | 200,000 |
| 2025-02-05 | Ferguson James J. III |
Chief Medical Officer | Other | 0 |
| 2025-02-05 | Ferguson James J. III |
Chief Medical Officer | Award | 60,000 |
| 2025-01-23 | Cole Jeffrey Scott |
Chief Operating Officer | Award | 25,000 |
| 2025-01-23 | WILSON GLYNN |
Director, Chief Executive Officer | Award | 20,000 |
| 2025-01-23 | MURPHY JOHN RAYMOND |
Director | Award | 20,000 |
| 2025-01-23 | Lisicki Robert |
Director, Chief Executive Officer | Award | 20,000 |
| 2025-01-23 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Award | 65,000 |
| 2025-01-23 | Szot Matthew K |
Director | Award | 50,000 |
| 2025-01-23 | Zelenkofske Steven |
Director | Award | 20,000 |
| 2024-04-10 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Other | 3,000,000 |
| 2024-04-10 | Pham Quang X |
Director, CEO and Chairman, 10% Owner | Gift | 50,000 |
| 2024-04-02 | Cole Jeffrey Scott |
Chief Operating Officer | Award | 150,000 |
| 2024-02-07 | Cole Jeffrey Scott |
Chief Operating Officer | Other | 0 |
Showing 1–50 of 93 transactions